Objectives: Owing to the severe donor shortage in Japan, living-donor lobar lung transplantation (LDLLT) remains a valuable option. As only lobes are implanted in LDLLT, grafts may be too small, especially for adult recipients. To overcome this obstacle, we developed right-to-left inverted LDLLT. In this procedure, the right lower lobe, which is 25% bigger than the left lower lobe, is used as the left-side graft instead of the left lower lobe. This study aimed to investigate the characteristics and intermediate outcomes of right-to-left inverted LDLLT.

Methods: Since the first right-to-left inverted LDLLT performed in 2014, 48 LDLLTs have been performed in our institution, of which 15 were right-to-left inverted LDLLTs. We reviewed their characteristics and intermediate outcomes.

Results: The reasons for choosing an inverted procedure instead of the standard LDLLT were small-for-size graft in 11 cases and anatomical variation of donor vessels in 4 cases. The first patient underwent left single LDLLT using a right lower lobe graft, and the following 14 patients underwent bilateral LDLLT using 2 right lower lobe grafts. A native upper lobe-sparing procedure was additionally applied in 2 patients. No complications occurred in the bronchial and vascular anastomoses. No operative mortality occurred, and all the patients were discharged home after LDLLT. The 3-year survival was 92.3%, with a median follow-up time of 40 months. The donor postoperative course was uneventful, and all the donors returned to their regular routine postoperatively.

Conclusion: Right-to-left inverted LDLLT is a safe and useful option with encouraging intermediate outcome.

Download full-text PDF

Source
http://dx.doi.org/10.1093/ejcts/ezz244DOI Listing

Publication Analysis

Top Keywords

right-to-left inverted
24
lower lobe
20
inverted ldllt
12
ldllt
9
intermediate outcomes
8
outcomes right-to-left
8
living-donor lobar
8
lobar lung
8
lung transplantation
8
left lower
8

Similar Publications

Article Synopsis
  • Infective endocarditis (IE) can occur in adults with ventricular septal defects (VSD), and this case reports a rare instance involving systemic embolisms and aortic pseudoaneurysms.
  • A 27-year-old woman with a previously asymptomatic VSD presented with prolonged fever and was found to have staphylococcus infection, heart murmurs, and serious complications like mycotic aneurysms and embolisms.
  • The patient received targeted antibiotics and underwent urgent heart surgery, emphasizing the importance of checking for systemic embolism in right ventricle IE and noting that congenital VSD can lead to serious complications from bacteremia.
View Article and Find Full Text PDF

Due to the difficulty of finding brain-dead donors, in October 1998, I performed the first living-donor lobar lung transplantation (LDLLT) for a ventilator-dependent 24-year-old female patient with bronchiectasis using lobes from her parents. The patient is still alive and in good health 25 years after the transplantation. Over time, the indications for LDLLT have expanded to include pulmonary hypertension, pulmonary fibrosis, congenital genetic diseases, pulmonary complications after stem cell transplantation, and, more recently, severe lung injury due to COVID-19 infection.

View Article and Find Full Text PDF

Lung transplants are still limited by the shortage of suitable donor lungs, especially during the coronavirus disease 2019 pandemic. A heterotopic lung transplant (HLTx), as a flexible surgical procedure, can maximize the potential of donor lungs in an emergency, but its widespread use is hindered by difficulties in anastomosis and paucity of outcome data. We performed a retrospective review of 4 patients, each of whom received an HLTxs over 1 year, including 1 left-to-right single HLTx, 2 right-to-left single HLTxs and 1 lobar HLTx (right upper lobe-to-left).

View Article and Find Full Text PDF

Living-donor lobar lung transplantation (LDLLT) has become an important life-saving option for patients with severe respiratory disorders in order to address the current severe shortage of brain-dead donor organs. Although LDLLT candidates were basically limited to critically ill patients who would require hospitalization, the long-term use of steroids, and/or mechanical respiratory support before transplantation, LDLLT provided good post-transplant outcomes, comparable to brain-dead donor lung transplantation( BDLT). In Kyoto University, the 1-, 5- and 10-year survival rates were 91%, 79% and 62% after LDLLT and 92%, 72% and 65% after BDLT, respectively.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!